$185,187,107

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

to CERUS CORPORATION

biotechactiveONGOING · MOD OF 2016 CONTRACT

WORK BEGAN2016-06-17·LATEST ACTION2026-05-18·SOURCEUSASPENDING·SOURCE IDCONT_AWD_HHSO100201600009C_7505_-NONE-_-NONE-

Award description

CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Latest obligation on a 2016 pathogen reduction technology contract with CERUS for blood and plasma safety systems.

Sub-sectors

pathogen-reduction-technologyblood-safetypandemic-preparedness

Why this matters

Pathogen reduction technology is critical infrastructure for pandemic preparedness and blood supply security; this 10-year program ensures U.S. capacity to neutralize transfusion-transmitted pathogens.

Supply-chain signal

Sustained federal investment signals stable demand for CERUS's proprietary PRT systems across U.S. blood banks and hospitals; supports domestic manufacturing of medical devices.

U.S.–China competition angle

Blood safety and pathogen reduction are strategic health-security assets; maintaining domestic capability reduces reliance on foreign suppliers for pandemic-critical medical countermeasures.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-22. Cost: $0.003056.

Period of performance

Start

2016-06-17

End

2026-09-30

Status

activein 92 days

Recipient

CERUS CORPORATION

UEI KJJQRRLY2FL5

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_HHSO100201600009C_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.